Global Absorbable Heart Stent Market is expected to reach USD 6.2 billion in 2023 from USD 3.1 billion in 2016 with a CAGR of approximately 9.6% during the forecast period 2017-2023.
In 2015, according to WHO reports, globally, the prevalence of cardiac disease in adults aged 18 and above was around 24.1% in men and 20.1% in women largely from low and middle income countries. Increasing unhealthy habits, lack of physical exercise and increasing prevalence of cardiac diseases contributed growth to the market. According to American college of cardiology, absorbable heart stent will replace the conventional metal stents in coming years. This is due to number of advantages of using absorbable heart stents. Most bioresorbable stents are made of polylactic acid. It is a naturally dissolvable material used in medical implants. Demand for absorbable heart stents is increasing due to advancement in technology of developing heart stents and increase in number of cardiac surgeries.
Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1175 .
On the other hand, there are few hurdles in the growth of this market. One of the biggest player in absorbable stent market, Abbott Vascular, has stopped manufacturing of its interventional cardiology product ABSORB GT. The company has terminated sales and operations related to this product in all the countries across the world due to the increased heart attack incidences with the use of its product. This major development may result in thwarting the growth of the market in the near future. However, market may regain its growth if the company resolves the issue in time and come up with better product in the market. Global absorbable heart stent market is expected to reach USD 6.2 billion by 2023 at a CAGR of 9.6% during forecast period 2017 to 2023.
Global Absorbable Heart Stent Market Players:
Key players in absorbable heart stent market are: Abbott Laboratories (U.S.), Biotronik (Germany), Arterial Remodeling Technologies SA (France), Amaranth Medical Inc. (U.S.), Kyoto Medical Planning Co. Ltd. (Japan), Elixir Medical Corporation (U.S.), and Reva Medical Inc. (U.S.).
Abbott Laboratories is an American healthcare company operating in more than 150 countries across the world. ABSORB GT is a bioresorbable vascular scaffold system manufactured by the company. In April 2016, the company entered into an agreement of acquiring St. Jude Medical thus strengthening its position in the market for heart stents and other vascular devices.
Order Single User License Copy of 80 Premium Pages is Available @ https://www.marketresearchfuture.com/reports/absorbable-heart-stent-market-1175 .
Biotronik is a multinational biotechnology company. Orsiro is a drug eluting stent and PK papyrus is a covered stent manufactured by the company. The company won Cardiostim Innovation Award for Best Practice Improvement in the year 2016.
Global absorbable heart stent market has been segmented on the basis of material used for bio absorbable stents which includes metal and polymer. The end users are hospitals, cardiac canters, research institutes and other users.
- Research Methodology
- Market Dynamics
- Market Factor Analysis
- Global Absorbable Heart Stent Market, By Type
- Global Absorbable Heart Stent Market, By End User
- Global Absorbable Heart Stent Market, By Region
- Competitive Landscape
- Company Profile
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/1175 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
+1 646 845 9312
- 11Avg Daily Vews
- 1 Day
- 1 Week
- 1 Month
- 2 Months
- 6 Months
- 1 Year